EXEL vs GILD
Exelixis, Inc. - Common Stock · Gilead Sciences, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | EXEL | GILD |
|---|---|---|
| Price | $60.99 | $153.54 |
| Market Cap | $15.11B | $190.38B |
| P/E | 19.31 | 22.37 |
| P/B | 8.20 | 16.09 |
| P/S | 6.51 | 6.47 |
| ROE | 42.4% | 71.9% |
| Net Margin | 33.7% | 28.9% |
| Gross Margin | — | — |
| Revenue Growth | 7.0% | 2.4% |
| Dividend Yield | — | 2.06% |
| EPS | $3.16 | $6.86 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.